Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Skeletal and extraskeletal myxoid chondrosarcoma: related or distinct tumors?

Rubin BP, Fletcher JA.

Adv Anat Pathol. 1999 Jul;6(4):204-12.

PMID:
10410173
2.

Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.

Antonescu CR, Argani P, Erlandson RA, Healey JH, Ladanyi M, Huvos AG.

Cancer. 1998 Oct 15;83(8):1504-21.

PMID:
9781944
3.

Myxoid chondrosarcoma (chordoid sarcoma) of bone: a report of two cases and review of the literature.

Kilpatrick SE, Inwards CY, Fletcher CD, Smith MA, Gitelis S.

Cancer. 1997 May 15;79(10):1903-10. Review.

PMID:
9149016
4.

t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases.

Sciot R, Dal Cin P, Fletcher C, Samson I, Smith M, De Vos R, Van Damme B, Van den Berghe H.

Mod Pathol. 1995 Sep;8(7):765-8. Review.

PMID:
8539235
5.

Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case.

Kumar R, Rekhi B, Shirazi N, Pais A, Amare P, Gawde D, Jambhekar N.

Diagn Cytopathol. 2008 Dec;36(12):868-75. doi: 10.1002/dc.20931. Review.

PMID:
18925568
6.

Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11).

Bjerkehagen B, Dietrich C, Reed W, Micci F, Saeter G, Berner A, Nesland JM, Heim S.

Virchows Arch. 1999 Nov;435(5):524-30.

PMID:
10592057
7.

Translocation (9;22)(q22;q12). A recurrent chromosome abnormality in extraskeletal myxoid chondrosarcoma.

Hirabayashi Y, Ishida T, Yoshida MA, Kojima T, Ebihara Y, Machinami R, Ikeuchi T.

Cancer Genet Cytogenet. 1995 May;81(1):33-7.

PMID:
7773957
8.

Genetics of chondrosarcoma and related tumors.

Sandberg AA.

Curr Opin Oncol. 2004 Jul;16(4):342-54. Review.

PMID:
15187889
9.

Skeletal myxoid chondrosarcoma with microtubular aggregates within rough endoplasmic reticulum.

Wolford JF, Bedetti CD.

Arch Pathol Lab Med. 1988 Jan;112(1):77-81.

PMID:
3337620
10.

Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.

Wang WL, Mayordomo E, Czerniak BA, Abruzzo LV, Dal Cin P, Araujo DM, Lev DC, López-Terrada D, Lazar AJ.

Mod Pathol. 2008 Nov;21(11):1303-10. doi: 10.1038/modpathol.2008.114. Epub 2008 Jun 27.

11.

Dedifferentiated chondrosarcoma with t(9;22)(q34;q11-12).

Tarkkanen M, Wiklund T, Virolainen M, Elomaa I, Knuutila S.

Genes Chromosomes Cancer. 1994 Feb;9(2):136-40.

PMID:
7513544
12.

Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.

Panagopoulos I, Mertens F, Isaksson M, Domanski HA, Brosjö O, Heim S, Bjerkehagen B, Sciot R, Dal Cin P, Fletcher JA, Fletcher CD, Mandahl N.

Genes Chromosomes Cancer. 2002 Dec;35(4):340-52.

PMID:
12378528
13.

Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma.

Turc-Carel C, Dal Cin P, Rao U, Karakousis C, Sandberg AA.

Cancer Genet Cytogenet. 1988 Jan;30(1):145-50.

PMID:
3422040
14.

Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2).

Harris M, Coyne J, Tariq M, Eyden BP, Atkinson M, Freemont AJ, Varley J, Attwooll C, Telford N.

Am J Surg Pathol. 2000 Jul;24(7):1020-6.

PMID:
10895826
15.

Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma.

Brody RI, Ueda T, Hamelin A, Jhanwar SC, Bridge JA, Healey JH, Huvos AG, Gerald WL, Ladanyi M.

Am J Pathol. 1997 Mar;150(3):1049-58.

16.

Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma.

Folpe AL, Agoff SN, Willis J, Weiss SW.

Am J Surg Pathol. 1999 Sep;23(9):1059-67.

PMID:
10478665
17.

Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases.

Okamoto S, Hisaoka M, Ishida T, Imamura T, Kanda H, Shimajiri S, Hashimoto H.

Hum Pathol. 2001 Oct;32(10):1116-24.

PMID:
11679947
18.

Der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeletal myxoid chondrosarcoma.

Day SJ, Nelson M, Rosenthal H, Vergara GG, Bridge JA.

Genes Chromosomes Cancer. 1997 Dec;20(4):425-7.

PMID:
9408761
19.

Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11).

Panagopoulos I, Mencinger M, Dietrich CU, Bjerkehagen B, Saeter G, Mertens F, Mandahl N, Heim S.

Oncogene. 1999 Dec 9;18(52):7594-8.

20.

Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics.

Hisaoka M, Hashimoto H.

Pathol Int. 2005 Aug;55(8):453-63. Review.

PMID:
15998372

Supplemental Content

Support Center